Sleepiness and Depression in Parkinson's Disease Patients Treated with Ropinirole and Levodopa
Journal of Movement Disorders
;
: 123-129, 2017.
Article
Dans Anglais
| WPRIM
| ID: wpr-90986
ABSTRACT
OBJECTIVE:
We aimed to investigate the effect of ropinirole on excessive daytime sleepiness (EDS) and depression in Parkinson’s disease (PD) with a large population.METHODS:
We conducted a cross-sectional observational study at nine hospitals in Korea between April 24, 2013, and April 22, 2015. We analyzed the demographic and clinical features, other medical history, history of antiparkinsonian medication within 6 months, Hoehn and Yahr stage (HY stage), Unified Parkinson’s Disease Rating Scale (UPDRS) part II and III, Epworth Sleepiness Scale (ESS), and 30-item Geriatric Depression Scale (GDS-30).RESULTS:
Four-hundred-thirteen patients with PD (mean age 65.2 ± 9.0 years; men 227 patients) were analyzed. Multivariate logistic regression analysis showed that age at examination, UPDRS II, and GDS-30 were independent risk factors for EDS and that sex, UPDRS II, and ESS were independent risk factors for depression.CONCLUSION:
Our large group study did not find any significant associations of ropinirole with EDS and depression in Korean PD patients.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Maladie de Parkinson
/
Lévodopa
/
Modèles logistiques
/
Facteurs de risque
/
Dépression
/
Étude d'observation
/
Corée
Type d'étude:
Etude d'étiologie
/
Étude observationnelle
/
Étude pronostique
/
Facteurs de risque
Limites du sujet:
Humains
/
Mâle
Pays comme sujet:
Asie
langue:
Anglais
Texte intégral:
Journal of Movement Disorders
Année:
2017
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS